Novo Nordisk L (0QIU)

1,118.00 +6.60 (+0.58%)
Real-time Data DKK Disclaimer

Novo Nordisk L Company Profile

Industry
Pharmaceuticals
Sector
Healthcare
Employees
54789
Equity Type
ORD
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Contact Information
Address
Bagsvaerd,2880 Denmark
Phone
45 44 44 88 88
Fax
-
Top Executives
Name
Age
Since
Title
Helge Lund 61 2017 Independent Chairman of the Board
Thomas Rantzau 51 2018 Employee Representative Non-Independent Director
Andreas Fibig 61 2018 Independent Director
Henrik Poulsen 56 2021 Vice Chairman of the Board
Laurence M. Debroux 54 2019 Independent Director
Liselotte Hyveled 57 2022 Employee Representative Director
Mette Bojer Jensen 48 2014 Employee Non-Independent Representative Director
Jesper Thorning 0 2018 Substitute Director
Elisabeth Dahl Christensen 58 2022 Employee Representative Director
Anders Kaae 0 2018 Substitute Director
Martin W. MacKay 67 2018 Independent Director
Sylvie L. Gregoire 62 2015 Independent Director
Tanja Villumsen 43 2018 Substitute Director
Karina Bonde Lenau 0 2018 Substitute Director
Christina Law 56 2022 Independent Director
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles